Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May 8;12(5):e8034.
doi: 10.7759/cureus.8034.

A Review of Cardiac Complications in Coronavirus Disease 2019

Romil Singh  1 , Rahul Kashyap  2 , Anneka Hutton  3 , Munish Sharma  4 , Salim Surani  4   5
Affiliations
Review

A Review of Cardiac Complications in Coronavirus Disease 2019

Romil Singh et al. Cureus. .

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has shown an association with acute myocardial injury, cardiomyopathy, and myocarditis. Individuals with myocardial involvement in association with the coronavirus disease 2019 (COVID-19) may be at increased risk of developing severe illness. Cardiomyopathies are a heterogeneous group of diseases of the myocardium associated with mechanical and/or electrical dysfunction that usually exhibit inappropriate ventricular hypertrophy or dilation and are due to a variety of causes that frequently are genetic. It has been primarily divided into three subsets: genetic, mixed, and acquired cardiomyopathy. We anticipate that, because of the high inflammatory response, other cardiovascular complications may also occur in COVID-19 patients with severe symptoms. This review explores new information as it pertains to COVID-19 and cardiac complications.

Keywords: cardiomyopathy; covid 19; heart failure; novel coronavirus; sars-cov-2.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Summary of COVID-19 and major cardiovascular abnormalities
COVID-19: coronavirus disease 19; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2
See this image and copyright information in PMC

References

    1. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. [Apr;2020 ];W.H.O W.H.O. http://www.who.int/dg/speeches/detail/who-director-general-s-opening-rem... 2020
    1. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) Johns Hopkins University and. http://coronavirus.jhu.edu/map.html 2020
    1. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. Shi S, Qin M, Shen B, et al. JAMA Cardiol. 2020;(Epub ahead of print) - PMC - PubMed
    1. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Maron BJ, Towbin JA, Thiene G, et al. Circulation. 2006;113:1807–1816. - PubMed
    1. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary artery risk development in (young) adults. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. https://doi.org/10.1161/01.CIR.92.4.785. Circulation. 1995;92:785–789. - PubMed

LinkOut - more resources